Invesco Ltd. Liquidia Corp Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Liquidia Corp stock. As of the latest transaction made, Invesco Ltd. holds 34,630 shares of LQDA stock, worth $794,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,630
Previous 649,037
94.66%
Holding current value
$794,758
Previous $9.57 Million
95.5%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LQDA
# of Institutions
209Shares Held
47.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$97.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$97.3 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$82.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$68.9 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$56.8 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.48B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...